ArticleMenopause (New York, N.Y.)2026

Utilization of fezolinetant for the treatment of moderate-to-severe vasomotor symptoms of menopause in a real-world setting.

Christine D Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.